In a landmark development set to redefine cancer care in Northeast India, the International Oncology Cancer Institute (IOCI) India, in partnership with ILS Hospitals, has officially inaugurated a state-of-the-art comprehensive cancer centre in Agartala, Tripura. The inauguration ceremony, attended by the Honourable Chief Minister of Tripura, marks a significant milestone in bringing world-class cancer diagnostics and treatment to the region.
This is the first corporate sector comprehensive cancer centre in Northeast India, reflecting IOCI’s commitment to bridging healthcare disparities by expanding access to advanced oncology services. The facility is housed within the ILS Hospitals campus in Agartala, a leading healthcare institution supported by the Government of Tripura since 2008. This strategic partnership unites IOCI’s oncology expertise with ILS Hospitals’ robust infrastructure and strong community presence to deliver integrated, patient-centric cancer care.
The Agartala centre is equipped with cutting-edge technologies, including the GE Discovery IQ PET CT scanner for high-precision cancer diagnostics and the ELEKTA SYNERGY linear accelerator, a global gold standard for precision radiation therapy. The centre also features a dedicated chemotherapy daycare, staffed by trained oncology nurses, providing a comfortable and safe setting for systemic treatments.
Already, the centre has shown remarkable impact—conducting over 300 PET CT scans in just six months before the official launch of its radiotherapy unit—highlighting both the community’s need and trust in the facility. The ELEKTA SYNERGY’s advanced imaging-guided radiation therapy capabilities, including IMRT and IGRT, allow for accurate tumor targeting with minimal damage to surrounding tissues, significantly improving patient outcomes and quality of life.
Dr. Madhur Garg, Promoter Director of IOCI, emphasized the broader vision: “This centre is not just about providing treatment—it is about bringing hope and healing to communities long underserved by modern oncology infrastructure. With the integration of diagnostics, chemotherapy, and precision radiation, we are offering a complete cancer care ecosystem under one roof.”
The facility’s registration under the Ayushman Bharat scheme ensures that economically vulnerable populations can access these life-saving treatments without financial strain, reinforcing the government’s vision of universal health coverage.
Dr. Ashvini Sengar, Promoter Director of IOCI, noted the transformative potential of the collaboration: “By combining IOCI’s technical capabilities with ILS Hospitals’ reach and reputation, we are creating a sustainable, high-impact model for regional cancer care.”
The centre also incorporates a multidisciplinary Tumor Board, where medical oncologists, radiation oncologists, and surgical specialists jointly assess cases to design personalized treatment plans. Surgical oncology services are available for a wide range of cancers, ensuring holistic care.
Dr. Pramod, Executive Director at IOCI, reiterated the patient-first approach: “From diagnosis to recovery, every touchpoint has been designed with empathy and clinical excellence. This is the future of cancer care—accessible, affordable, and patient-focused.”
The establishment of IOCI Agartala is a major step forward in decentralizing advanced cancer care, reducing the burden of travel to distant metros, and strengthening the healthcare infrastructure in Northeast India. With its technological edge, compassionate care, and commitment to accessibility, the centre stands as a beacon of hope for cancer patients across the region.